Luca Boscolo Bielo

[AntonSafonovMD @AntonSafonovMD]

So excited to share our latest work with @PedramRazaviMD, @MSKCancerCenter, and Sarat Chandarlapaty out today in @Nature. https://t.co/CGDIcHQe5f (1/n)

[ESMO Open @ESMO_Open]

Retrospective analysis of MTB impact on the care of patients with GI tumors at @IEOufficiale just published in @ESMO_Open. Among 192 patients discussed at the MTB, 31 (17.7%) were recommended molecularly guided treatment options, experiencing longer rwPFS. https://t.co/79Vl4n5Txh

[Davide Ciardiello @DCiardiello]

Pleased to share our latest manuscript published in @ESMO_Open 📢

@BoscoloLuca_ @Giulia_Martini1 @erikamartin3lli @MassimoDiMaio75 @ChiaraCrem1 @napolitano_ste @latiano_titty @alfdestefano @curijoey @curijoey

https://t.co/dZens2plg0

[Luca Boscolo Bielo @BoscoloLuca_]

@BenWestphalen @myESMO @OncoAlert @VivekSubbiah Amazing team!!!

[Ben Westphalen @BenWestphalen]

Kicking of anew #OpenAccess new series in @myESMO Gastrointestinal #Oncology —> Exploring the pathway  🔎

Thanks to Lena Weiss & @BoscoloLuca_ for doing the heavy lifting!

#PrecisionMedicine @OncoAlert 🚨@VivekSubbiah

https://t.co/FxaKYnJVj8

[Luca Boscolo Bielo @BoscoloLuca_]

@DCiardiello @IEOufficiale @AIOMtweet @Giulia_Martini1 @curijoey @latiano_titty @NicolaNormanno @erikamartin3lli Congrats Davide!!!

[Davide Ciardiello @DCiardiello]

The full paper is finally hot of the press in @Annals_Oncology 🔊
@Giulia_Martini1 @curijoey @NicolaNormanno @erikamartin3lli @myESMO @IEOufficiale
🔽
https://t.co/TdKWbvBiRm

[Abeid Athman (Omar). @bin_abeid]

Don't forget to pass by our poster (abstract 406P) in Hall 6, Zone A on the sixth row on your right.
#ESMO2024 @myESMO @curijoey @stolaney1 @darioT_ @BoscoloLuca_ @matteolambe @kevinpunie @OncoAlert @DrSGraff @HamidMD10 @Annals_Oncology

[Luca Boscolo Bielo @BoscoloLuca_]

@Erman_Akkus @darioT_ @trendscancer @CellPressNews An unexplored biomarker with a huge biological rationale behind @curijoey @antoniomarraMD

[G Curigliano MD PhD @curijoey]

Variant allele frequency: a decision-making tool in precision oncology...a thread https://t.co/Pjp49XyLwy

[Luca Boscolo Bielo @BoscoloLuca_]

@echo_stepbystep @VDelgadoGarcia @EACVIPresident @denisamuraru @Sarah_Moharem @HanCardiomd @NMerke @DrJamal_Khan @DrGEMandoli A tetralogy of Fallot for the books

[Luca Boscolo Bielo @BoscoloLuca_]

@neerajaiims @ASCO @OncoAlert @PCF_Science @MedIQCME @montypal @DrChoueiri @PGrivasMDPhD @Daniel_J_George @Huntsman_GU @nsayeghmd @TripNish @umangtalking @PBarataMD @cancermd Classic example of a skewed ITT analysis driven by a small subgroup of patients gaining major benefits. Conclusions are debatable